|
End-of-day quote
OTC Markets
19/11/2026
|
5-day change | 1st Jan Change | ||
| 1.270 USD | +27.00% |
|
-85.40% | -91.09% |
| Market Cap | 1L 1L 94.64T 85.61T 2L 1.05Cr 2L 11.44L 5L 56.63L 4L 4L 1.79Cr | P/E 2024 |
-0.08x | P/E 2025 | 26.6x |
|---|---|---|---|---|---|
| Enterprise Value | 5.45Cr 4.97Cr 4.6Cr 4.16Cr 7.8Cr 509.27Cr 8.17Cr 56Cr 22Cr 275.2Cr 20Cr 20Cr 871.74Cr | EV / Sales 2024 |
2.43x | EV / Sales 2025 | 2.76x |
| Free-Float |
100% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +27.00% | ||
| 1 week | -85.40% | ||
| Current month | -85.89% | ||
| 1 month | -86.56% | ||
| 3 months | -88.86% | ||
| 6 months | -86.12% | ||
| Current year | -91.09% |
| 1 week | 1 | 9.9 | |
| 1 month | 1 | 10.5 | |
| Current year | 1 | 16.2 | |
| 1 year | 1 | 20.4 | |
| 3 years | 1 | 338.98 | |
| 5 years | 1 | 15,18,560.18 | |
| 10 years | 1 | 3,53,20,584.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 01/01/2018 | |
Ivy Zhang
DFI | Director of Finance/CFO | 49 | 13/04/2023 |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | - | |
Colin Rutherford
BRD | Director/Board Member | 67 | 01/01/2018 |
Kim Kamdar
BRD | Director/Board Member | 58 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/01/24 | Sell | Chief Financial Officer | 104 | 0.0010% | ||
| 21/12/23 | Sell | Director | 10 | 0.0001% | ||
| 13/04/23 | Other | Chief Financial Officer | 13,000 | 0.0107% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +27.00% | -85.40% | -91.45% | -98.79% | 1L | ||
| -2.29% | -5.34% | +28.73% | +128.34% | 1,20400Cr | ||
| -2.04% | -5.78% | +31.91% | +78.34% | 64TCr | ||
| -0.86% | -3.71% | +21.74% | +105.02% | 50TCr | ||
| -0.14% | -1.58% | +27.74% | +67.95% | 38TCr | ||
| -3.61% | -9.62% | +39.73% | +30.53% | 33TCr | ||
| +0.52% | -4.68% | +27.25% | +51.61% | 28TCr | ||
| +1.07% | -3.78% | -1.44% | +33.13% | 27TCr | ||
| -1.14% | -6.05% | +28.16% | +65.35% | 24TCr | ||
| -1.45% | -0.85% | +30.03% | +120.72% | 21TCr | ||
| Average | +2.70% | -12.59% | +14.24% | +58.22% | 41TCr | |
| Weighted average by Cap. | +0.08% | -4.71% | +27.08% | +88.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.94Cr 1.76Cr 1.63Cr 1.48Cr 2.77Cr 180.84Cr 2.9Cr 20Cr 7.83Cr 98Cr 7.26Cr 7.11Cr 309.55Cr | 2.02Cr 1.84Cr 1.7Cr 1.54Cr 2.89Cr 188.5Cr 3.02Cr 21Cr 8.16Cr 101.86Cr 7.57Cr 7.41Cr 322.66Cr |
| Net income | -88.6L -80.72L -74.73L -67.59L -1.27Cr -83Cr -1.33Cr -9.03Cr -3.58Cr -45Cr -3.32Cr -3.25Cr -141.64Cr | 4L 4L 3L 3L 6L 3.65Cr 6L 39.86L 15.81L 1.97Cr 14.67L 14.36L 6.25Cr |
| Net Debt | 4.58Cr 4.18Cr 3.87Cr 3.5Cr 6.56Cr 428.12Cr 6.87Cr 47Cr 19Cr 231.34Cr 17Cr 17Cr 732.83Cr | 5.44Cr 4.96Cr 4.59Cr 4.15Cr 7.79Cr 508.22Cr 8.15Cr 55Cr 22Cr 274.63Cr 20Cr 20Cr 869.94Cr |
Employees
29
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | $1.270 | +27.00% | 553 |
| 18/26/18 | $1.000 | -84.50% | 880 |
| 17/26/17 | $6.450 | -28.93% | 1,796 |
| 16/26/16 | $9.075 | -2.42% | 24 |
| 13/26/13 | $9.300 | +6.90% | 24 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- EVFM.D Stock
Select your edition
All financial news and data tailored to specific country editions
















